piracetam has been researched along with Epilepsy Progressive Myoclonic 2 in 2 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lafora disease is one of the rare, most fatal progressive myoclonic epilepsies reported." | 1.36 | Role of levetiracetam in refractory seizures due to a rare progressive myoclonic epilepsy: Lafora body disease. ( Ehtesham, Z; Hashmi, M; Mustafa, MS; Saleem, F; Sheerani, M; Siddiqui, K, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aydoğan, H | 1 |
| Yalçn, S | 1 |
| Karahan, MA | 1 |
| Büyükfrat, E | 1 |
| Hashmi, M | 1 |
| Saleem, F | 1 |
| Mustafa, MS | 1 |
| Sheerani, M | 1 |
| Ehtesham, Z | 1 |
| Siddiqui, K | 1 |
2 other studies available for piracetam and Epilepsy Progressive Myoclonic 2
| Article | Year |
|---|---|
Pancytopenia associated with levetiracetam treatment in Lafora's disease.
Topics: Adolescent; Aged; Anticonvulsants; Female; Humans; Lafora Disease; Levetiracetam; Pancytopenia; Pira | 2012 |
Role of levetiracetam in refractory seizures due to a rare progressive myoclonic epilepsy: Lafora body disease.
Topics: Adolescent; Anticonvulsants; Biopsy; Fatal Outcome; Humans; Lafora Disease; Levetiracetam; Male; Pir | 2010 |